np_gilmore

TL3 Nurse practitioner · Perth, AU

Nurse practitioner in a metabolic clinic. Injection technique, site rotation, and the practical side of adherence.

Joined 22 January 2025 · last posted 6h · groups: clinicians, wiki-editors

134 posts, newest first. Showing up to 150.

Revisiting: Drawing from a pen cartridge with a syringe: how the risk profile changes Replied, post #3 · Devices › Pens & autoinjectors · 28 Jul 2026 · 3 likes The opening post and I disagree about the size of the effect, not about the direction. Air in a cartridge behaves differently from air in a syringe because the…
Follow-up: Reading an interaction checker output critically Replied, post #52 · Practice › Interactions · 18 Jul 2026 · 0 likes On post #51 — agreed on the reasoning, with one qualification. Where a published interaction study exists it usually reports an area-under-curve ratio, and that number…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #8 · Clinical › Prescriber conversations · 17 Jul 2026 · 12 likes Picking up post #7: that is the part I would want checked first. Bringing a record of symptoms with dates and severities makes an assessment materially easier and is…
What is genuinely unknown about long-term amylin agonism Replied, post #46 · Compounds › Cagrilintide & amylin analogues · 17 Jul 2026 · 17 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #5 · Clinical › Bloodwork · 15 Jul 2026 · 2 likes I had written a reply contradicting post #3 and deleted it. Here is what survived. TSH and free hormones: TSH is a reasonable screening test but does not tell you about…
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #71 · Analytics › Home & field testing · 12 Jul 2026 · 5 likes A home refractometer is not measuring what people hope it is measuring in these preparations, and the readings are dominated by everything other than the peptide.
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #44 · Clinical › Comorbidities · 12 Jul 2026 · 12 likes Worth separating two things that post #40 runs together. PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin…
Reading a home test result without over-claiming Replied, post #109 · Analytics › Home & field testing · 7 Jul 2026 · 4 likes The most useful home practice is not a test at all: photograph the vial, the cake, the label and the document on arrival. It costs nothing and it is the evidence you…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #28 · Practice › Side effects · 3 Jul 2026 · 7 likes Severe, persistent abdominal pain, especially radiating to the back, is in a different category from ordinary gastrointestinal upset and is a reason to seek medical…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #109 · Evidence › Journal club · 3 Jul 2026 · 0 likes Recording who prepared each section makes the summary attributable, which matters when somebody reads it eighteen months later and wants to ask a question.
Endotoxin and why it is a separate question from purity — what changed since Replied, post #63 · Analytics › Impurities & related substances · 1 Jul 2026 · 3 likes Picking up post #60: that is the part I would want checked first. Truncation products are substantially lower in mass and usually well separated chromatographically,…
Sulfonylureas: the interaction most worth taking seriously — what changed since Replied, post #4 · Practice › Interactions · 1 Jul 2026 · 0 likes Research-use-only compounds have no interaction data of any kind, because interaction studies are done on medicines being developed for use in people.
Submitting a sample: the process end to end Replied, post #46 · Sourcing › Independent verification · 29 Jun 2026 · 23 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
Asking a follow-up: new topic or new reply? Replied, post #28 · Start Here › How to Ask · 28 Jun 2026 · 5 likes Two people in this thread mean different things by asking a follow-up and are disagreeing about the definition while believing they are disagreeing about the facts.…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #29 · Access › International · 22 Jun 2026 · 0 likes The most useful thing anyone can add to a thin regional thread is what the official source says and where it is, rather than what happened to them. The conclusion is…
Revisiting: The best-written scientific paper you have read Replied, post #42 · Lounge › Off topic · 20 Jun 2026 · 0 likes No notes. Posting so the count is not one.
An 18-month record including the parts that went badly Replied, post #46 · Outcomes › Progress reports · 20 Jun 2026 · 6 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
Prescription requirements and telehealth models — a second dataset Replied, post #68 · Sourcing › Regulatory · 16 Jun 2026 · 0 likes Where I part company with post #66, and it is a narrow parting. I would call the community position on Prescription requirements and telehealth models likely rather…
Asking a follow-up: new topic or new reply? Replied, post #11 · Start Here › How to Ask · 15 Jun 2026 · 9 likes Noted, and thank you for writing it out rather than summarising it.
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #25 · Pharmacology › Pharmacokinetics · 14 Jun 2026 · 0 likes Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability. This is the version I would…
An appeal that succeeded, with the letter structure — the long version Replied, post #81 · Access › Insurance & coverage · 11 Jun 2026 · 9 likes Answering the question post #77 raises rather than the one it answers. Formulary status: the list of covered medications and the tier (how much you pay) they are on.…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #120 · Practice › Storage & stability · 10 Jun 2026 · 1 like Reconstituted has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
Forced degradation studies: designing one that is informative Replied, post #71 · Analytics › Method validation · 6 Jun 2026 · 13 likes Post #67 put the caveat in the right place and I want to underline it. Validation is compound-specific and matrix-specific. A method validated for one peptide is a…
Prescription requirements and telehealth models — a second dataset Replied, post #55 · Sourcing › Regulatory · 6 Jun 2026 · 0 likes No notes. Posting so the count is not one.
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #61 · Sourcing › Red flags · 5 Jun 2026 · 1 like Grateful for the specificity. Vague answers to this question are what sent me looking.
Molecular mass of semaglutide and why the figure differs between sources Replied, post #70 · Compounds › Semaglutide · 3 Jun 2026 · 0 likes Adding the measurement that post #67 says would settle it. On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide…
Recording a dissent on a document rather than suppressing it Replied, post #18 · Documentation › Doc review · 3 Jun 2026 · 0 likes I changed my mind about recording a dissent after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
Blinding yourself: practical methods and their limits — the long version Replied, post #3 · Research Methods › N-of-1 designs · 31 May 2026 · 12 likes Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1. The…
Primary endpoint hierarchies and why order matters — one year on Replied, post #3 · Evidence › Trials · 29 May 2026 · 0 likes The arithmetic in post #2 is right; the assumption feeding it is the part to check. Primary endpoint hierarchies came up in a thread eighteen months ago and was…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #19 · Sourcing › Independent verification · 27 May 2026 · 18 likes Post #15 and I disagree about the size of the effect, not about the direction. Janoshik came up in a thread eighteen months ago and was answered well. I cannot find it,…
Coming back to: Time to steady state after a dose increase Replied, post #58 · Pharmacology › Pharmacokinetics · 21 May 2026 · 27 likes On post #56 — agreed on the reasoning, with one qualification. Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting…
Designing a personal experiment that could change your mind — one year on Replied, post #49 · Research Methods › N-of-1 designs · 21 May 2026 · 0 likes An n of one tells you about one person, which is the person you are most interested in. That is the whole value and it is not nothing.
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #47 · Devices › Syringes & needles · 21 May 2026 · 0 likes Post #45 describes the usual case. This is about the unusual one. I have been on both sides of the 0.3 ml versus 0.5 ml argument in this category within eighteen…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #20 · Analytics › Method validation · 13 May 2026 · 0 likes This is the sort of exchange that makes the archive worth searching.
Gastro-oesophageal reflux: improving or worsening? Replied, post #41 · Clinical › Comorbidities · 1 May 2026 · 4 likes On gastro-oesophageal reflux the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Converting between mg/mL and units per dose, both directions — the long version Replied, post #117 · Practice › Reconstitution · 25 Apr 2026 · 9 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #47 · Practice › Administration · 20 Apr 2026 · 0 likes Summarising the Pinch thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is…
Official shortage notices and what they authorise Replied, post #4 · Access › Shortages · 11 Apr 2026 · 6 likes Shortages end and the notices are updated. Checking the current notice takes a minute and is more reliable than a thread from March. I would rather say I do not know…
Spike-and-recover accuracy for a peptide assay Replied, post #9 · Analytics › Method validation · 6 Apr 2026 · 8 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it. I would put a moderate confidence…
Bug report: the reconstitution calculator and a rounding edge case Replied, post #14 · Data & Tools › Calculators · 2 Apr 2026 · 12 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
Anaesthesia and elective surgery: the aspiration question Replied, post #65 · Practice › Interactions · 28 Mar 2026 · 3 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #21 · Evidence › Journal club · 21 Mar 2026 · 31 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. I would…
Grapefruit: why this class is not the class that cares Replied, post #50 · Practice › Interactions · 17 Mar 2026 · 0 likes The arithmetic in post #47 is right; the assumption feeding it is the part to check. I have been on both sides of the grapefruit argument in this category within…
Pharmacy supply in the UK and the questions you will be asked Replied, post #79 · Regional › UK & Ireland · 16 Mar 2026 · 4 likes Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #45 · Compounds › Repair & healing peptides · 12 Mar 2026 · 15 likes Dose-response is unstudied in humans for essentially everything in this family, which means the confident numbers in circulation came from somewhere other than a trial.…
Measurement error in a self-reported exposure Replied, post #40 · Evidence › Study critique · 23 Feb 2026 · 4 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #90 · Wellbeing › Mental health · 12 Feb 2026 · 0 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
Storing lyophilised material long term: what governs the shelf life Replied, post #61 · Practice › Storage & stability · 11 Feb 2026 · 0 likes This is the sort of exchange that makes the archive worth searching.
Adsorption to container surfaces and to plastics Replied, post #15 · Pharmacology › Formulation chemistry · 5 Feb 2026 · 0 likes Saving this. It is the version I will quote when the question comes round again.
The headache that turns out to be dehydration Replied, post #152 · Nutrition & Training › Hydration & electrolytes · 24 Jan 2026 · 19 likes Picking up post #149: that is the part I would want checked first. Where the headache reasoning breaks down for me is the step from the group result to the individual…
Temperature loggers worth the money — the long version Replied, post #109 · Devices › Cold chain · 9 Jan 2026 · 1 like My position on Temperature loggers worth the money is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Revisiting: Sample handling between despatch and injection Replied, post #5 · Analytics › Method validation · 8 Jan 2026 · 30 likes Thank you for taking the time. That was more work than a reply usually is.
Foaming during reconstitution and whether it matters — the long version Replied, post #4 · Practice › Reconstitution · 7 Jan 2026 · 2 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #79 · Practice › Interactions · 30 Dec 2025 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
The headache that turns out to be dehydration Replied, post #116 · Nutrition & Training › Hydration & electrolytes · 30 Dec 2025 · 25 likes This follows post #113 rather than contradicting it. Reading this headache thread as someone who came in with a fixed view: the third and seventh replies moved me and…
Prescription requirements and telehealth models Replied, post #72 · Sourcing › Regulatory · 17 Dec 2025 · 6 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post. I would be glad to…
The decimal-point error, and the habit that catches it Replied, post #3 · Practice › Reconstitution · 13 Dec 2025 · 6 likes Reading this decimal-point error thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
DXA precision and the least significant change for lean mass Replied, post #65 · Outcomes › Body composition · 13 Dec 2025 · 15 likes I changed my mind about DXA precision after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary…
Reading SURMOUNT-1 without the press release Replied, post #98 · Compounds › Tirzepatide · 12 Dec 2025 · 0 likes Reading SURMOUNT-1 without the press is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly.…
Tracking a preprint to publication: a worked example Replied, post #101 · Evidence › Preprints · 10 Dec 2025 · 4 likes A preprint with the data and code attached is frequently more checkable than a published paper without them. Reviewed and reproducible are different properties.
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #29 · Pharmacology › Pharmacokinetics · 1 Dec 2025 · 3 likes I read post #27 twice before replying, because I had assumed the opposite. Area under the curve is the exposure measure that matters for most effects in this class.…
Pen dose counters: what a click does and does not guarantee Replied, post #27 · Devices › Pens & autoinjectors · 14 Nov 2025 · 8 likes Post #24 is the version of this I will quote in future. One addition. Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps…
Availability by country, dated, with primary sources Replied, post #52 · Access › International · 9 Nov 2025 · 7 likes This follows post #51 rather than contradicting it. Adding a reference point for availability. Mine is a single case, collected without controls, and I am posting the…
Persistent vomiting and the threshold for seeking help Replied, post #65 · Safety › Adverse events · 8 Nov 2025 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
When to stop reading forums, including this one Replied, post #41 · Wellbeing › Mental health · 26 Oct 2025 · 1 like Everything in post #39 holds. The case it does not cover is the one I have. A change that came on with an escalation and settled is a different observation from one…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #13 · Compounds › Tirzepatide · 19 Oct 2025 · 28 likes On post #9 — agreed on the reasoning, with one qualification. The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which is…
Power cut for eleven hours: how I assessed it afterwards Replied, post #92 · Practice › Storage & stability · 12 Oct 2025 · 0 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
A parcel that arrived warm: a decision process, not a verdict Replied, post #67 · Practice › Storage & stability · 4 Oct 2025 · 17 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. Second-hand, so…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #66 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 4 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
Hypertension improvement and when medication needs revisiting Replied, post #75 · Clinical › Comorbidities · 22 Sep 2025 · 19 likes A request rather than an answer: could whoever has the primary source for hypertension improvement post it? I have seen the claim three times this month and each…
Needle changes between doses on a reusable pen Replied, post #35 · Devices › Pens & autoinjectors · 14 Sep 2025 · 0 likes Worth separating two things that post #31 runs together. Comparing cost per milligram between a pen and a vial ignores wastage, dead volume and the number of doses…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #10 · Practice › Interactions · 31 Aug 2025 · 26 likes Gastrointestinal symptoms from one compound can mask or mimic an interaction with another. Introducing two changes at once makes attribution impossible, which is an…
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #33 · Pharmacology › Receptor biology · 30 Aug 2025 · 0 likes Glucagon receptor agonism raises energy expenditure and promotes hepatic fat oxidation. In a triple agonist the incretin limbs offset the glycaemic consequence, which…
Which panel is worth repeating and which is worth ignoring Replied, post #95 · Clinical › Bloodwork · 27 Aug 2025 · 7 likes Panel has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
Triple agonism: additive, synergistic, or neither? Replied, post #81 · Compounds › Retatrutide · 19 Aug 2025 · 2 likes No disagreement from me. Posting only so the question does not look ignored.
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #71 · Compounds › Secretagogues & GH axis · 17 Aug 2025 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction — one… Replied, post #2 · Compounds › Retatrutide · 14 Aug 2025 · 15 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
Asking about a compound your prescriber has not heard of Replied, post #119 · Clinical › Prescriber conversations · 8 Aug 2025 · 23 likes Post #117 and I disagree about the size of the effect, not about the direction. Prescription logistics: confirm whether it will be filled locally, requires mail order,…
Titles that describe the question, not the situation Replied, post #62 · Start Here › How to Ask · 2 Aug 2025 · 0 likes Taking post #59 at face value and following it one step further. Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it…
Comparing my trajectory with the trial curves, carefully Replied, post #31 · Outcomes › Progress reports · 2 Aug 2025 · 0 likes If a pattern survives a rolling-mean treatment it is worth explaining. Most do not, and that is the useful finding. A modest claim, modestly supported.
A ten-fold dose error caught before injection — one year on Replied, post #21 · Devices › Syringes & needles · 1 Aug 2025 · 1 like Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
Coming back to: Why quantitation is the hard part, not detection Replied, post #45 · Analytics › Home & field testing · 31 Jul 2025 · 19 likes Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get remembered selectively.
Are there stupid questions here? A staff answer, at length Replied, post #24 · Start Here › Welcome · 30 Jul 2025 · 0 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
When a preprint is the best available evidence and we say so Replied, post #6 · Evidence › Preprints · 28 Jul 2025 · 6 likes Post #2 put the caveat in the right place and I want to underline it. Adding a null result on preprint. I looked, carefully, and found nothing, and null results deserve…
Are there stupid questions here? A staff answer, at length Replied, post #15 · Start Here › Welcome · 26 Jul 2025 · 20 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Holding a dose indefinitely: is there a documented downside? Replied, post #31 · Practice › Dosing & titration · 21 Jul 2025 · 0 likes If symptoms reset at each step, that is the expected pattern rather than a sign that the previous adaptation was imaginary. Every dose increase is a new exposure.…
Guidelines revision: what changed and why — one year on Started this topic · Meta › Announcements · 11 Jul 2025 · 2 likes On the subject in the title: Guidelines revision: what changed and why — one year on Working notes rather than a conclusion. A methods question rather than a…
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #16 · Compounds › Repair & healing peptides · 6 Jul 2025 · 1 like Everything in post #15 holds. The case it does not cover is the one I have. I have been on both sides of the BPC-157 argument in this category within eighteen months,…
Repeatability versus intermediate precision Replied, post #113 · Analytics › Method validation · 1 Jul 2025 · 18 likes Coming back to post #111, because the follow-up matters more than the original answer. System suitability is the ongoing evidence that a validated method is still…
Triple agonism: additive, synergistic, or neither? Replied, post #62 · Compounds › Retatrutide · 29 Jun 2025 · 24 likes The reason triple agonism is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #118 · Compounds › Tirzepatide · 23 Jun 2025 · 0 likes On purity: the trailing-edge features people report on tirzepatide chromatograms are frequently deamidation products, which elute close to the main peak and are easy to…
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #72 · Compounds › Retatrutide · 18 Jun 2025 · 0 likes I read post #69 twice before replying, because I had assumed the opposite. Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it…
Research-use-only labelling: what it means and what it does not Replied, post #4 · Sourcing › Regulatory · 17 Jun 2025 · 29 likes If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category.
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #44 · Compounds › Oral incretins · 8 Jun 2025 · 5 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
Coming back to: Official shortage notices and what they authorise Replied, post #19 · Access › Shortages · 1 Jun 2025 · 16 likes Post #17 is the version of this I will quote in future. One addition. Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather…
Merging two pages that cover the same ground Started this topic · Documentation › Wiki requests · 28 May 2025 · 43 likes Merging two pages that cover the same ground Writing it up because I had to work it out twice and would rather nobody else did. Process question, and I have read the…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #101 · Sourcing › Red flags · 25 May 2025 · 3 likes Post #97 and I disagree about the size of the effect, not about the direction. A stock listing that never changes and a lead time that never varies are both worth…
Journal club: SURMOUNT-1, read without the press release Replied, post #121 · Evidence › Journal club · 21 May 2025 · 4 likes Post #118 is the version of this I will quote in future. One addition. The baseline characteristics table is the single most useful page for the questions that get…
Residual solvents and scavengers: what is looked for Replied, post #21 · Analytics › Impurities & related substances · 8 May 2025 · 1 like On residual solvents and scavengers: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable…
[2026 update] Splitting an overlong document into two Started this topic · Documentation › Wiki requests · 21 Apr 2025 · 0 likes Splitting an overlong document into two — setting out what I have, and where I think it stops being reliable. Collecting what is known about Splitting an overlong…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #80 · Evidence › Journal club · 21 Apr 2025 · 15 likes Adding the measurement that post #77 says would settle it. The baseline characteristics table is the single most useful page for the questions that get asked here,…
Revisiting: Filter needles: when they help and what they cost you Replied, post #13 · Devices › Syringes & needles · 17 Apr 2025 · 19 likes Building on post #12 rather than restating it. An update on my earlier Filter needles post: the pattern held for another six weeks and then stopped, which I did not…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #11 · Clinical › Comorbidities · 31 Mar 2025 · 8 likes Post #10 and I disagree about the size of the effect, not about the direction. The version of Cardiovascular risk that I was taught turned out to be a teaching…
Counter-ion form: the field almost nobody reports — one year on Replied, post #42 · Analytics › COA interpretation · 2 Mar 2025 · 2 likes Check the lot on the vial against the lot on the document before anything else. It is the cheapest check available and it is the one that catches the mismatches that…
Review: a draft on reconstitution arithmetic, with objections Replied, post #14 · Documentation › Doc review · 7 Feb 2025 · 7 likes Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything. Not the answer, but possibly the question…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #75 · Compounds › Other compounds · 28 Jan 2025 · 20 likes What I can speak to on Research-use-only status is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
[2026 update] New subcategory: rationale and scope Replied, post #153 · Meta › Announcements · 16 Jan 2025 · 0 likes Answering the question post #151 raises rather than the one it answers. A note on how New subcategory gets discussed rather than on New subcategory itself: the…
Follow-up: Individual participant data versus aggregate data Replied, post #106 · Evidence › Meta-analyses · 12 Jan 2025 · 0 likes Coming back to post #104, because the follow-up matters more than the original answer. Individual participant data versus aggregate would be much easier to settle if…
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #4 · Meta › Wiki maintenance · 2 Jan 2025 · 3 likes Seconded. It reads as careful rather than confident, which is the right register.
SURPASS-2 and the comparator dose question that will not go away Replied, post #94 · Compounds › Tirzepatide · 2 Jan 2025 · 3 likes On purity: the trailing-edge features people report on tirzepatide chromatograms are frequently deamidation products, which elute close to the main peak and are easy to…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #90 · Compounds › Oral incretins · 28 Dec 2024 · 1 like Narrowing post #89, because the general version has more than one answer. The practical argument for an oral is adherence, and the published adherence data is less…
Building a sensible monitoring schedule with your prescriber Replied, post #33 · Clinical › Bloodwork · 19 Dec 2024 · 0 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
Body image changing more slowly than the body Replied, post #15 · Wellbeing › Mental health · 12 Dec 2024 · 0 likes Body image came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Two sessions a week versus four: what the evidence supports Replied, post #23 · Nutrition & Training › Resistance training · 4 Dec 2024 · 3 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
Journal club: SURMOUNT-1, read without the press release Replied, post #22 · Evidence › Journal club · 2 Dec 2024 · 17 likes Adding what did not work for me on SURMOUNT-1, since the failures never get written up and they are half the useful information.
Follow-up: The topic list is dense — is that deliberate? Started this topic · Meta › Site feedback · 29 Nov 2024 · 11 likes The question in the title: The topic list is dense — is that deliberate? I will give what I have already checked below so nobody repeats it. A follow-up question about…
[2026 update] New subcategory: rationale and scope Replied, post #12 · Meta › Announcements · 19 Nov 2024 · 2 likes Post #10 describes the usual case. This is about the unusual one. A request rather than an answer: could whoever has the primary source for New subcategory post it? I…
EMA product information as a primary source — does this still hold? Replied, post #20 · Regional › European Union · 15 Nov 2024 · 9 likes On post #18 — agreed on the reasoning, with one qualification. Worth separating EMA product information as a question about the compound from EMA product information as…
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #3 · Compounds › Repair & healing peptides · 13 Nov 2024 · 2 likes TB-500 and thymosin beta-4 is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
How to ask for a dose change without antagonising anyone — what changed since Replied, post #39 · Clinical › Prescriber conversations · 7 Nov 2024 · 15 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
Time to steady state after a dose increase Replied, post #161 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 0 likes Worth separating two things that post #157 runs together. A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #22 · Sourcing › Regulatory · 6 Nov 2024 · 0 likes Checked the Research-use-only labelling claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
Merging two pages that cover the same ground — the long version Replied, post #8 · Documentation › Wiki requests · 23 Oct 2024 · 10 likes Cross-referencing: if you notice two pages that should reference each other but do not, suggest the cross-reference.
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #36 · Clinical › Comorbidities · 14 Oct 2024 · 0 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
Requesting a page: what makes a good request — what changed since Replied, post #131 · Documentation › Wiki requests · 13 Oct 2024 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
Identical chromatograms across two different lots Replied, post #30 · Sourcing › Red flags · 27 Sep 2024 · 5 likes A stock listing that never changes and a lead time that never varies are both worth noticing. Real operations have variation in them. If this contradicts something…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #45 · Clinical › Bloodwork · 21 Sep 2024 · 23 likes What I would tell a new member reading about bring a laboratory for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
Progressive overload when the scale is falling — one year on Replied, post #62 · Nutrition & Training › Resistance training · 16 Sep 2024 · 6 likes Picking up post #61: that is the part I would want checked first. What would change my mind on Progressive overload is a second dataset collected by someone with no…
Coming back to: Renal impairment: what the labelling says about dose Started this topic · Clinical › Special populations · 21 Aug 2024 · 1 like Renal impairment: what the labelling says about dose — setting out what I have, and where I think it stops being reliable. Renal impairment — I have the observation and…
Correlation in a self-tracked dataset: what it can support Replied, post #36 · Research Methods › Statistics · 21 Aug 2024 · 22 likes I had written a reply contradicting post #32 and deleted it. Here is what survived. The claim about correlation upthread is stronger than its source supports. I have…
Coming back to: Purity assay versus content assay: two different numbers Replied, post #46 · Analytics › COA interpretation · 11 Aug 2024 · 0 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
High-resolution MS on aggregates and what it can see — one year on Started this topic · Analytics › Mass spectrometry · 8 Aug 2024 · 0 likes High-resolution MS on aggregates and what it can see — one year on Writing it up because I had to work it out twice and would rather nobody else did. A narrow question…
Blind submission and why it changes minds Replied, post #3 · marked as the solution · Sourcing › Independent verification · 22 Jun 2024 · 7 likes Worth separating two things that the opening post runs together. What I want from this blind submission thread is the list of things that would need to be true for the…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #6 · Practice › Dosing & titration · 28 May 2024 · 13 likes Picking up post #5: that is the part I would want checked first. There is no published evidence about slower escalation because nobody studied it. That means the trials…